TY - JOUR
T1 - Children and Adults With Frequent Hospitalizations for Asthma Exacerbation, 2012-2013
T2 - A Multicenter Observational Study
AU - Multicenter Airway Research Collaboration-37 Investigators
AU - Hasegawa, Kohei
AU - Bittner, Jane C.
AU - Nonas, Stephanie A.
AU - Stoll, Samantha J.
AU - Watase, Taketo
AU - Gabriel, Susan
AU - Herrera, Vivian
AU - Camargo, Carlos A.
AU - Aurora, Taruna
AU - Brenner, Barry
AU - Brown, Mark A.
AU - Calhoun, William
AU - Gough, John E.
AU - Gutta, Ravi C.
AU - Heidt, Jonathan
AU - Khosravi, Mehdi
AU - Moore, Wendy C.
AU - Mould-Millman, Nee Kofi
AU - Nowak, Richard
AU - Ahn, Jason
AU - Pei, Veronica
AU - Press, Valerie G.
AU - Probst, Beatrice D.
AU - Ramratnam, Sima K.
AU - Hartman, Heather
AU - Snipes, Carly
AU - Teuber, Suzanne S.
AU - Trent, Stacy A.
AU - Villarreal, Roberto
AU - Youngquist, Scott
N1 - Funding Information:
This study was supported by Novartis Pharmaceuticals Corporation (principal investigator C.A.C. Jr). The sponsor had no role in the conduct of the study, nor collection, management, or analysis of the data.
Funding Information:
Conflicts of interest: S. A. Nonas has received research support from the National Institutes of Health -National Heart, Lung, and Blood Institute (K08 grant, HL089178). S. Gabriel is employed by Novartis Pharmaceuticals Corporation. V. Herrera is employed by, and owns stock/stock options in Novartis Pharmaceuticals Corporation. C. A. Camargo Jr has received research support from Novartis and has received consultancy fees for asthma-related consultation from GlaxoSmithKline, Meck, Novartis, and Teva. The rest of the authors declare that they have no relevant conflicts of interest.
Publisher Copyright:
© 2015 American Academy of Allergy, Asthma & Immunology.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Background: Earlier studies reported that many patients were frequently hospitalized for asthma exacerbation. However, there have been no recent multicenter studies to characterize this patient population with high morbidity and health care utilization. Objective: To examine the proportion and characteristics of children and adults with frequent hospitalizations for asthma exacerbation. Methods: A multicenter chart review study of patients aged 2 to 54 years who were hospitalized for asthma exacerbation at 1 of 25 hospitals across 18 US states during the period 2012 to 2013 was carried out. The primary outcome was frequency of hospitalizations for asthma exacerbation in the past year (including the index hospitalization). Results: The cohort included 369 children (aged 2-17 years) and 555 adults (aged 18-54 years) hospitalized for asthma exacerbation. Over the 12-month period, 36% of the children and 42% of the adults had 2 or more (frequent) hospitalizations for asthma exacerbation. Among patients with frequent hospitalizations, guideline-recommended outpatient management was suboptimal. For example, among adults, 32% were not on inhaled corticosteroids at the time of index hospitalization and 75% had no evidence of a previous evaluation by an asthma specialist. At hospital discharge, among adults with frequent hospitalizations who had used no controller medications previously, 37% were not prescribed inhaled corticosteroids. Likewise, during a 3-month postdischarge period, 64% of the adults with frequent hospitalizations were not referred to an asthma specialist. Although the proportion of patients who did not receive these guideline-recommended outpatient care appeared higher in adults, these preventive measures were still underutilized in children; for example, 38% of the children with frequent hospitalizations were not referred to asthma specialist after the index hospitalization. Conclusions: This multicenter study of US patients hospitalized with asthma exacerbation demonstrated a disturbingly high proportion of patients with frequent hospitalizations and ongoing evidence of suboptimal longitudinal asthma care.
AB - Background: Earlier studies reported that many patients were frequently hospitalized for asthma exacerbation. However, there have been no recent multicenter studies to characterize this patient population with high morbidity and health care utilization. Objective: To examine the proportion and characteristics of children and adults with frequent hospitalizations for asthma exacerbation. Methods: A multicenter chart review study of patients aged 2 to 54 years who were hospitalized for asthma exacerbation at 1 of 25 hospitals across 18 US states during the period 2012 to 2013 was carried out. The primary outcome was frequency of hospitalizations for asthma exacerbation in the past year (including the index hospitalization). Results: The cohort included 369 children (aged 2-17 years) and 555 adults (aged 18-54 years) hospitalized for asthma exacerbation. Over the 12-month period, 36% of the children and 42% of the adults had 2 or more (frequent) hospitalizations for asthma exacerbation. Among patients with frequent hospitalizations, guideline-recommended outpatient management was suboptimal. For example, among adults, 32% were not on inhaled corticosteroids at the time of index hospitalization and 75% had no evidence of a previous evaluation by an asthma specialist. At hospital discharge, among adults with frequent hospitalizations who had used no controller medications previously, 37% were not prescribed inhaled corticosteroids. Likewise, during a 3-month postdischarge period, 64% of the adults with frequent hospitalizations were not referred to an asthma specialist. Although the proportion of patients who did not receive these guideline-recommended outpatient care appeared higher in adults, these preventive measures were still underutilized in children; for example, 38% of the children with frequent hospitalizations were not referred to asthma specialist after the index hospitalization. Conclusions: This multicenter study of US patients hospitalized with asthma exacerbation demonstrated a disturbingly high proportion of patients with frequent hospitalizations and ongoing evidence of suboptimal longitudinal asthma care.
UR - http://www.scopus.com/inward/record.url?scp=84941259735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941259735&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2015.05.003
DO - 10.1016/j.jaip.2015.05.003
M3 - Article
C2 - 26028297
AN - SCOPUS:84941259735
VL - 3
SP - 751-758.e1
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
SN - 2213-2198
IS - 5
ER -